Brief: India's Strides Pharma Science Dec-Quarter Consol Loss Narrows
24/01/2023 09:16
Jan 24 (Reuters) - Strides Pharma Science Ltd SRID.NS :
* DEC-QUARTER CONSOL LOSS AFTER TAX FROM CONTOPS 821.1
MILLION
RUPEES VERSUS LOSS 1.27 BILLION RUPEES
* DEC-QTR CONSOL REV FROM OPS 8.65 BLN RUPEES VS 7.94 BLN
RUPEES
YR AGO
Further company coverage: SRID.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Strides Pharma Science
See all newsIndia's Strides Pharma jumps on successful closure of USFDA inspection at Bengaluru facility
Brief: Strides Pharma Science Receives USFDA EIR For Flagship Facility In Bengaluru
Brief: Strides Pharma Science Receives US FDA Establishment Inspection Report For Bengaluru Facility
Brief: Strides Pharma Science June-Quarter Consol Net Profit 1.57 Billion Rupees
Brief: Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees